Publications by authors named "David Milich"

Claim this Profile
A
A Lyophilizable Nanoparticle Vaccine Specific for a Novel Linear Neutralizing Epitope in the α2-α3 Helices of Domain 3 of Lethal Factor from .
Jon Oscherwitz, Kemp Cease, David Milich, Thomas Braun, Fen Yu

Toxins (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Lyophilizable Nanoparticle Anthrax Vaccine Targeting the Loop-Neutralizing Determinant in Protective Antigen from .
Jon Oscherwitz, Kemp Cease, David Milich, Tod Merkel, Thomas Braun

Microorganisms· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the function of the HBeAg really unknown?
David R Milich

Hum Vaccin Immunother· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Concept of Immune Tolerance in Chronic Hepatitis B Virus Infection Is Alive and Well.
David R Milich

Gastroenterology· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections.
David C Whitacre, Diego A Espinosa, Cory J Peters, Joyce E Jones, Amy E Tucker, David R Milich

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.
Jeanne H Schickli, David C Whitacre, Roderick S Tang, Jasmine Kaur, Heather Lawlor, David R Milich

J Clin Invest· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional aspects of intrahepatic hepatitis B virus-specific T cells induced by therapeutic DNA vaccination.
Anette Brass, Lars Frelin, David R Milich, Matti Sällberg, Gustaf Ahlén

Mol Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a unique double-negative regulatory T-cell population.
Byung O Lee, Joyce E Jones, Cory J Peters, David Whitacre, Lars Frelin, David R Milich

Immunology· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination.
Antony Chen, Gustaf Ahlén, Erwin D Brenndörfer, Anette Brass, Fredrik Holmström, David R Milich

J Immunol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.
Keith Ameiss, Shamaila Ashraf, Wei Kong, Andrew Pekosz, Wai-Hong Wu, David Milich

Vaccine· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytes.
Jessica Nyström, Antony Chen, Lars Frelin, Gustaf Ahlén, Sarene Koh, David R Milich

J Infect Dis· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of hepadnavirus core proteins as vaccine platforms.
David C Whitacre, Byung O Lee, David R Milich

Expert Rev Vaccines· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of the hepatitis B core antigen and the innate immune system.
Byung O Lee, Amy Tucker, Lars Frelin, Matti Sallberg, Joyce Jones, David R Milich

J Immunol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection.
Lars Frelin, Therese Wahlström, Amy E Tucker, Joyce Jones, Janice Hughes, David R Milich

J Virol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms.
Jean-Noel Billaud, Darrell Peterson, Byung O Lee, Toshiyuki Maruyama, Antony Chen, David Milich

Vaccine· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative antigenicity and immunogenicity of hepadnavirus core proteins.
Jean-Noel Billaud, Darrell Peterson, Florian Schödel, Antony Chen, Matti Sallberg, David Milich

J Virol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial approach to hepadnavirus-like particle vaccine design.
Jean-Noel Billaud, Darrell Peterson, Margaret Barr, Antony Chen, Matti Sallberg, David Milich

J Virol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune tolerance split between hepatitis B virus precore and core proteins.
Margaret Chen, Matti Sällberg, Janice Hughes, Joyce Jones, Luca G Guidotti, David R Milich

J Virol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.
Margaret T Chen, Jean-Noel Billaud, Matti Sällberg, Luca G Guidotti, Francis V Chisari, David R Milich

Proc Natl Acad Sci U S A· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.
David Milich, T Jake Liang

Hepatology· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenetics of the response to HBsAg vaccination.
David R Milich, Geert G Leroux-Roels

Autoimmun Rev· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A malaria vaccine candidate based on a hepatitis B virus core platform.
Matti Sällberg, Janice Hughes, Joyce Jones, Tom R Phillips, David R Milich

Intervirology· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent.
Una Lazdina, Mats Alheim, Jessica Nyström, Catharina Hultgren, Gallina Borisova, David R Milich

J Gen Virol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of C4A deficiency on nonresponse to HBsAg vaccination: a new immune response gene.
David R Milich

J Hepatol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.
Una Lazdina, Catharina Hultgren, Lars Frelin, Margaret Chen, Karin Lodin, David R Milich

J Gen Virol· June 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis